by Ryan Hall | Jul 7, 2022 | Uncategorized
Review of FDA July 2022 DSCSA Draft Guidance on Identifying Trading Partners Written-by: Sumeet Singh, CEO As we rocket towards the Event Horizon of the November 2023 DSCSA implementation deadline, industry and FDA are each figuring out how exactly the law will be...
by Ryan Hall | Apr 7, 2022 | Uncategorized
FDA Proposed Rules Review, Part 2 of 4: 3PL Licensing Standards & Approved Organizations Oversight Written-by: Sumeet Singh, CEO FDA Proposed Rules. In this second part of the review of the FDA’s proposed rules, we focus on the national standards the FDA seeks to...
